Application of chidamide in combination with r-chop, and drug combination
AssigneesShenzhen Chipscreen Biosciences Co., Ltd., Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
InventorsWeili ZHAO, Ting LIU, Xianping LU, Pengpeng XU, Xin FU
Life of this patent
Estimating the term…
Abstract
The present application provides an application of Chidamide in combination with R-CHOP in preparing a drug used for treating B-cell lymphoma, and also provides a drug comprising Chidamide and R-CHOP. Chidamide in combination with R-CHOP has a synergistic therapeutic effect on B-cell lymphoma.
Claims8
(canceled)
(canceled)
(canceled)
(canceled)
A method for treating B-cell lymphoma, which is characterized by simultaneously, separately or sequentially administering Chidamide, rituximab, cyclophosphamide, adriamycin or epirubicin, vincristine and prednisone in an effective dose.
A combination drug, comprising Chidamide, rituximab, cyclophosphamide, adriamycin or epirubicin, vincristine and prednisone in an effective dose for simultaneous, separate or sequential administration.
Dependencies are inferred from the claim text.